Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Sulfur burps on Mounjaro are common due to slowed gastric emptying, altered gut flora, and dietary changes, and most cases resolve with meal size adjustments, smaller bites, and over the counter remedies. However, several factors like ongoing severity beyond six weeks or alarming symptoms such as pain, blood, fever, or dehydration could signal a red flag.
See below for the full checklist, practical tips for management, and guidance on when to contact your healthcare provider.
Starting Mounjaro (tirzepatide) can bring positive changes in blood sugar control and weight loss, but it may also trigger new gastrointestinal sensations—including the unpleasant "sulfur burps." If you've noticed Mounjaro sulfur burps after starting your treatment, you're not alone. Below is a practical checklist to help you decide whether these burps are within the expected side-effect range or if they warrant medical evaluation.
Sulfur burps are belches that smell like rotten eggs. They result from hydrogen sulfide gas in your digestive tract. This gas can build up when:
While annoying, sulfur burps are common and often benign. However, persistent or severe symptoms may indicate an underlying issue, especially when starting a new medication like Mounjaro.
Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes and, more recently, for chronic weight management. Common gastrointestinal side effects include nausea, vomiting, diarrhea and burping. Here's why sulfur burps can occur:
Use this checklist to gauge whether your sulfur burps are likely a routine side effect or a sign you should seek immediate medical attention.
Duration & Frequency
Associated Symptoms
Impact on Daily Life
Home Remedies & Dietary Changes
Most cases respond well to lifestyle and dietary changes. Try the following strategies:
Keep a simple food diary to identify any specific triggers. If you notice certain foods consistently precede sulfur burps, reduce or space out their consumption.
While most sulfur burps on Mounjaro are manageable, certain warning signs require prompt attention. Contact your healthcare provider or seek emergency care if you experience:
For non-urgent concerns—such as new or worsening digestive symptoms—you can quickly assess your symptoms using a Medically approved LLM Symptom Checker Chat Bot to help determine whether you need to contact your healthcare provider right away.
Always keep your prescribing clinician informed about any side effects you experience while on Mounjaro. When you speak to your doctor, be prepared to discuss:
Your doctor may recommend:
Mounjaro's benefits—improved blood sugar control and weight reduction—often outweigh manageable side effects. However, persistent or severe sulfur burps can affect your comfort and quality of life. By following the checklist above, making simple adjustments, and staying in close contact with your healthcare team, you can maintain the advantages of Mounjaro while keeping unwanted gas symptoms in check.
By staying informed and proactive, you can navigate sulfur burps without losing sight of the significant health gains Mounjaro offers. If in doubt, reach out to your healthcare provider immediately—especially if you notice signs of serious complications.
(References)
* Heise T, et al. Efficacy and Safety of Tirzepatide, a Dual GIP and GLP-1 Receptor Agonist, in People with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetes, Obesity and Metabolism. 2022 Mar;24(3):477-488. doi: 10.1111/dom.14603. Epub 2022 Jan 10. PMID: 34961912.
* Min T, et al. Tirzepatide Slows Gastric Emptying in Healthy Subjects. Diabetes Obes Metab. 2022 Mar;24(3):489-498. doi: 10.1111/dom.14604. Epub 2022 Jan 10. PMID: 34961913.
* Frias JP, et al. Tirzepatide versus insulin glargine in type 2 diabetes and high cardiovascular risk: SURPASS-4 randomised trial. Lancet. 2021 Jul 24;398(10295):141-156. doi: 10.1016/S0140-6736(21)01058-0. Epub 2021 Jun 25. PMID: 34175023.
* Coskun T, et al. Tirzepatide: A Review of its Role in the Management of Type 2 Diabetes. Drugs. 2022 Sep;82(13):1415-1428. doi: 10.1007/s40265-022-01777-6. Epub 2022 Aug 23. PMID: 35997705.
* Nauck MA, et al. Gastrointestinal adverse events with GLP-1 receptor agonists: an updated meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2017 Jul;19(7):1066-1067. doi: 10.1111/dom.12938. Epub 2017 Apr 24. PMID: 28318047.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.